Trial Profile
Clinical Trials Insight: 700056499
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 May 2010
Price :
$35
*
At a glance
- Drugs Minnelide (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 27 May 2010 New trial record